hightech
Commented by André Will-Laudien on March 17th, 2025 | 07:20 CET
After the NASDAQ correction – Hightech on the rebound: Palantir, Amazon, MiMedia, SMCI, and Intel on the rise
The NASDAQ correction was sharp and brief, with a 15% drop from 22,200 to 19,100 in just 4 weeks. In the context of a normal consolidation, that might be enough to bring the heavily overbought tech stocks back to normal levels. Unfortunately, however, there are also valid fundamental reasons that can be traced back to the official chaos of the new US President, Donald Trump. He is making wild tariff demands and withdrawing key resources from all international partnerships. This departure from normal political behavior could have a much more significant impact on the stock market, as global trade relations are faltering, while inflation and currency devaluation continue. Which tech stocks should be considered now?
Read
Commented by Juliane Zielonka on March 13th, 2025 | 07:00 CET
Big Pharma's billion-dollar markets under pressure – NetraMark as the key for Bayer and Novo Nordisk?
In 2025, the pharmaceutical market faces significant challenges, including rising costs and regulatory hurdles. In this environment, companies like NetraMark, Bayer, and Novo Nordisk could make a significant difference through innovative solutions and strategic partnerships. NetraMark, a Canadian HealthTech company, is revolutionizing clinical trials with AI technology, which could be particularly beneficial in the areas of research into active ingredients for the central nervous system and in oncology. These are currently the biggest dropouts in industry. NetraMark's technology could increase the efficiency of drug development and open up new opportunities for investors. Bayer is focusing on targeted therapies in precision oncology and has a promising drug in development that specifically targets an overarching mutation in various cancers. Novo Nordisk is cementing its reputation as an innovator in the fight against chronic obesity, particularly with its successor to the obesity drug CagriSema. The Phase III REDEFINE 2 study achieved its primary objective, although the results fell short of high expectations. A closer look is now warranted.
Read
Commented by Juliane Zielonka on March 12th, 2025 | 06:55 CET
Eutelsat, MiMedia, Xiaomi – The infrastructure for the networking markets of the future, worth billions
Millions of people in emerging markets are gaining access to digital markets – a potential of great importance to investors. The French satellite communications company Eutelsat is realizing this with its satellites such as EUTELSAT KONNECT, which bring broadband internet to remote regions of Africa and the Middle East, opening up billion-dollar markets. Eutelsat is particularly active in Europe, Africa, the Middle East, and Asia. The software company MiMedia is profiting from this connectivity by providing its cloud platform on Android smartphones. The software is the small tile for your users' pictures on the smartphone, preinstalled upon activation. MiMedia achieves this implementation through partnerships such as with América Móvil, one of the largest telecommunications providers in LATAM. MiMedia, with roots in New York City, is already expanding in Africa, reaching millions of users. The Chinese tech company Xiaomi complements this with affordable hardware: With 43.1 million smartphones shipped in Q3 2024 and the new Xiaomi 15 series, it is tapping into global markets, seamlessly integrated into cloud and satellite networks. Together, they are creating an infrastructure that generates billions of dollars in revenue in high-growth regions.
Read
Commented by Fabian Lorenz on March 11th, 2025 | 07:20 CET
Is a 100% rally on the horizon? Evotec, D-Wave, and AI pearl NetraMark
The sell-off in the tech sector continues at the beginning of the week. If sentiment changes, a 100% rally could start. At least, that is what analysts at D-Wave expect. Overall, analysts take a positive view of last year's quantum star. The development of the AI pearl NetraMark is also positive. With its NetraAI platform, the Company aims to revolutionize the development of drugs. The first customers are in place, and the latest study data is promising. Even in the current sell-off, the stock wants to go up. The positive news is currently evaporating at Evotec. The stock is threatening to fall below EUR 6. Are there further write-offs?
Read
Commented by André Will-Laudien on March 11th, 2025 | 07:10 CET
Olalla! And here comes the consolidation! Are these already buying opportunities for SMCI, Benton Resources, Palantir, and Meta?
Whenever investors use the term "one-way street", the market tends to correct. This time, several factors were at play, such as failed peace efforts, rising debt, increasing interest rates, and the threat of tariffs from the Trump administration. All four points have a long-term recessive effect, as they weaken consumer sentiment and purchasing power due to higher interest rates and product payments. In the short term, they also weigh on overheated growth portfolios. It is, therefore, worthwhile to take a closer look at the well-known protagonists. After all, buying opportunities arise time and again – timing is key!
Read
Commented by André Will-Laudien on March 6th, 2025 | 07:00 CET
NETRAMARK HOLDINGS – Medical Revolution: How AI is Shortening Drug Approval by Years!
Artificial Intelligence – now it is really taking off in the medical field! Among many other applications, big data and artificial intelligence (AI) applications are revolutionizing the optimization of clinical phases in drug approval by accelerating processes, reducing costs, and significantly increasing the success rate. AI can analyze large amounts of data from electronic health records, genomic data, and patient registries to identify suitable clinical trial participants more quickly and accurately. This significantly reduces recruitment time and improves accuracy. Machine learning can be used to analyze previous study results to develop more efficient study designs. Based on real-time data, adaptive study protocols enable dynamic adjustment of experimental conditions. The Canadian technology company NetraMark Holdings Inc. (WKN: A3D5X9 | ISIN: CA64119M1059 | Ticker symbol: AIAI) develops solutions for the pharmaceutical industry to utilize Generative Artificial Intelligence (Gen AI).
Read
Commented by Stefan Feulner on March 5th, 2025 | 08:00 CET
C3.ai, Credissential, Strategy – Strong momentum
Donald Trump has many plans and visions associated with his slogan "Make America Great Again". One of these is that the "capital for artificial intelligence and cryptocurrencies" should be located in the United States. With the Stargate Project, which has a volume of over USD 500 billion, a program for investing in AI has been approved. Over the weekend, the Republican followed up by introducing a strategic cryptocurrency reserve, which caused the introduced currency pairs to take off.
Read
Commented by Armin Schulz on March 4th, 2025 | 07:10 CET
Deutsche Telekom, MiMedia, Xiaomi – On the trail of powerful growth drivers
Today, we are looking at three companies that have recently caused a stir. All of them are active in promising fields of technology, rely on intelligent expansion, and deliver impressive growth figures. Whether through smart product innovations, collaborations with industry giants, or global market strategies – they are united by the pursuit of efficiency and sustainable success. In this context, the Mobile World Congress 2025 in Barcelona is making headlines this month. New network standards, AI-supported services, and global partnerships illustrate the surge in innovation from which these three companies are also benefiting.
Read
Commented by Armin Schulz on March 3rd, 2025 | 07:10 CET
Super Micro Computer, naoo, Palantir – Competing for the Tech future with artificial intelligence
While tech giants like Alphabet and Microsoft are making headlines in January with investment announcements of over USD 300 billion in data centers, innovative companies are pushing their way into niche markets in the shadow of these corporations. Driven by artificial intelligence and disruptive business models, they reflect the ambivalence of today's tech markets, which are characterized by rapid growth but also extreme price fluctuations. Three companies stand out – Super Micro Computer is taking advantage of the hype surrounding AI servers, Naoo is revolutionizing social media through gamification and by linking with local retailers, and Palantir is dominating data-driven decision-making. What do they have in common? They have created a moat for themselves through innovation and could thus be the winners of the upcoming tech era.
Read
Commented by André Will-Laudien on February 28th, 2025 | 08:00 CET
Caution - Nasdaq correction: Now, it is really starting with Palantir, Alibaba, Naoo AG, and Meta Platforms.
After a brief correction, the stock market is accelerating again. Alongside high-tech and AI fantasies, rumors of peace surrounding Ukraine are also gaining momentum. European stocks likely to play a role in any reconstruction are gaining a lot of attention. But high-tech is also back in demand. With Nvidia's figures exceeding market expectations, there is some minor profit-taking, but the strong trend should continue. Especially with Nvidia, investors have become accustomed to corrections being offset in a few days. Nevertheless, investors should be on their guard, as many valuations are already very ambitious. In the messenger area, we discovered Naoo AG, which was founded in Switzerland. With innovative approaches, a multifunctional app is being developed here that could potentially outperform even Meta in certain areas. A closer look makes sense.
Read